Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

6.1%

45 terminated/withdrawn out of 734 trials

Success Rate

89.1%

+2.6% vs industry average

Late-Stage Pipeline

20%

145 trials in Phase 3/4

Results Transparency

11%

40 of 369 completed trials have results

Key Signals

73 recruiting40 with results34 terminated11 withdrawn

Enrollment Performance

Analytics

N/A

178(32.4%)

Phase 2

169(30.8%)

Phase 4

86(15.7%)

Phase 3

59(10.7%)

Phase 1

56(10.2%)

Early Phase 1

1(0.2%)

549Total

N/A(178)

Phase 2(169)

Phase 4(86)

Phase 3(59)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (734)

Showing 20 of 734 trials

NCT07735897Not Yet Recruiting

Long Term Cohort Study of Adding Ovarian Function Suppression to Tamoxifen in Young Women

Role: collaborator

NCT06184009Phase 2Recruiting

Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia

Role: collaborator

NCT06099366Phase 2Recruiting

Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children

Role: collaborator

NCT06257394Phase 2Recruiting

Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea

Role: collaborator

NCT04782375Phase 4Completed

Safely Discontinue Antiviral Treatment in Patients With Chronic Hepatitis B

Role: lead

NCT07730840Phase 3Not Yet Recruiting

Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke

Role: lead

NCT07485855Phase 3Recruiting

Influenza Vaccination Strategy for Patients With Hematologic Malignancy

Role: lead

NCT07726901Not ApplicableRecruiting

Empirical Anatomy-Based Ablation vs Emphasize Map-Guided Substrate Ablation in Persistent Atrial Fibrillation : (COMPASS-AF)

Role: collaborator

NCT06929897Not ApplicableEnrolling By Invitation

PVI Alone vs PVI With Posterior Wall Isolation for Pulse-Field Ablation in Persistent AF

Role: collaborator

NCT05148286Phase 4Recruiting

Albumin and Crystalloid Administration in Septic Shock

Role: lead

NCT07010497Phase 2Recruiting

A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular Carcinoma

Role: lead

NCT07431762Phase 4Recruiting

Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprosthetic Heart Valve Replacement

Role: lead

NCT07670962Not Yet Recruiting

Blood-Based Minimal Residual Disease in Advanced Epithelial Ovarian Cancer After 1st Line Therapy

Role: lead

NCT06735716Active Not Recruiting

Comparison of Safety and Efficacy Between the Robot-assisted System AVIAR (MX-02) Procedure and Conventional Manual Procedure in Patients Requiring Percutaneous Coronary Intervention

Role: lead

NCT05807841Recruiting

Clinical Impact of Intravascular Ultrasound-Based Artificial Intelligence Technologies (INNOVATE-PCI)

Role: lead

NCT05418556Phase 4Recruiting

Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent

Role: lead

NCT06144125Phase 4Recruiting

Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery

Role: collaborator

NCT07556770Completed

Sonographic Safety Margins of Subclavian Vein: Effect of View and Arm Position

Role: lead

NCT07641283Not ApplicableNot Yet Recruiting

Naltrexone for Nonsuicidal Self-Injury

Role: collaborator

NCT06937463Not ApplicableCompleted

Use of an Off-the-Shelf Exergame as an In-Bed Gamified Rehabilitation Intervention for Severely Deconditioned Inpatients: A Feasibility Study

Role: lead